This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationRequest
Resource MedicationRequest "medicationrequest0301-discontinue"
identifier: http://www.bmc.nl/portal/medstatements
/med0301-studyDrug (use: official)
status: stopped
intent: order
Reference |
|
subject: Patient/ClinicalTrialSubject5 " CLINICAL TRIAL"
authoredOn: 1905-08-23
requester: : Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD
Concept |
Psoriasis (SNOMED CT#9014002) |
Text | Route | Method |
500mg IV q6h x 3 days | Intravenous route (qualifier value) (SNOMED CT#47625008) | IV Push () |
Generated Narrative: Medication #med0301
code: Study Medication for psoriasis ()